Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07190755

Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)

Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Curative Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) With Radiotherapy or Chemoradiotherapy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
192 (estimated)
Sponsor
Centre Henri Becquerel · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.

Conditions

Interventions

TypeNameDescription
OTHERRemote symptoms moniotringParticipants in the intervention arm will use Resilience PRO, a mobile phone application regularly asking participants about their symptoms. For clinically important symptoms, an alert is sent to the care team that can incorporate that information to timely adjust the care of the participants.

Timeline

Start date
2025-10-15
Primary completion
2030-06-01
Completion
2030-06-01
First posted
2025-09-24
Last updated
2025-12-30

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07190755. Inclusion in this directory is not an endorsement.